Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
06/2003
06/25/2003EP1320546A2 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof
06/25/2003EP1320545A2 Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen
06/25/2003EP1320379A2 Use of replication-deficient poxvirus vector to boost cd4+ t cell immune response to antigen
06/25/2003EP1320376A2 Treatment of prostate cancer
06/25/2003EP1320292A2 Method of cloning porcine animals
06/25/2003EP1137798A4 A method of isolating stem cells
06/25/2003EP0980205B1 Use of a combination of tall-104 cells with adriamycin or cisplatin in the therapy of malignancies
06/25/2003EP0979031B1 Methods for plant transformation and regeneration
06/25/2003EP0707498B1 Implantable prosthesis, kit and device for manufacturing the same
06/25/2003EP0679182B1 Delivery of gene products via mesangial cells
06/25/2003EP0678121B1 Methods and reagents for inhibiting furin endoprotease
06/25/2003EP0620849B1 Transgenic animal models for alzheimer's disease
06/25/2003EP0563189B1 Genetically engineered modification of potato to form amylopectin-type starch
06/25/2003EP0480024B1 Dna encoding plant thioesterases
06/25/2003CN1426477A 方法 Method
06/25/2003CN1426475A Method and compositions to reduce or eliminate transmission of transgene
06/25/2003CN1426472A Nucleic acid construct encoding processing component derived from N-terminal region of hepatitis virus ORF2, and an antigenic polypeptide
06/25/2003CN1426468A KCNB: novel potassium channel protein
06/25/2003CN1426467A Thrombopoietin receptor modulating peptide
06/25/2003CN1426466A Genetic silencing
06/25/2003CN1426465A Construct capable of release in closed circular form from larger nucleotide sequence permitting site specific expression and/or developmentally regulated expression of genetic sequences
06/25/2003CN1426463A Cutinase variants
06/25/2003CN1426461A Method of producing membrane vesicles
06/25/2003CN1426423A Humanized antibodies that sequester amyloid beta peptide
06/25/2003CN1426421A Tumour-specific animal proteins
06/25/2003CN1426306A Method and compositions for impairing multiplication of HIV-1
06/25/2003CN1426289A Method for expansion of epithelial stem cells
06/25/2003CN1425764A In situ cancer cell cloning animal test research method
06/25/2003CN1425763A Use of icariin in inducing external oriented differentiation of embryo stem cells
06/25/2003CN1112445C Control of plant gene expression
06/25/2003CN1112443C Starch branching enzyme II of potato
06/25/2003CN1112442C Cell retaining and separating method and device for cell deposition culture process
06/24/2003US6583336 Generation of transgenic plant; obtain cells, incubate with expression vector, transform cells, recover transformed cells, propagate in nutrient broth
06/24/2003US6583290 14-methyl epothilone derivatives
06/24/2003US6583277 Which regulate cellular guidance and physiology, and related nucleic acids.
06/24/2003US6583276 Nucleotide sequences coding polypeptide for use in the treatment of cardiovascular disorders
06/24/2003US6583121 System for the in vivo delivery and expression of heterologous genes in the bone marrow
06/24/2003US6583112 Gene products related to werner's syndrome
06/24/2003US6583107 Hypersensitive response elicitor fragments eliciting a hypersensitive response and uses thereof
06/24/2003US6582961 Generating disease resistant plants; obtain plant, incubate with vector coding preferential enzymatic polypeptides, transform, recover transformed plants, propagate, monitor plant resistance to disease
06/24/2003US6582960 Generation of preferential chrondrocytes tissue; provide tissue, culture with fibroblast growth factor 2, propagate and harvest cells, generate tissue
06/24/2003US6582957 Lipoxygenase proteins and polynucleotides encoding the same
06/24/2003US6582935 Isolated nucleic acid molecules encoding human aspartate aminotransferase protein and uses thereof
06/24/2003US6582913 Detection of nucleotide sequence polymorphism; obtain nucleotide sequences sampple, determine nucleotide sequence, compare to control, detect adjustment in nucleotide sequences
06/24/2003US6582909 Genotyping biological sample; obtain sample, extract nucleotide sequence, sequence, compare to control, detect adjustments in sequences, score
06/24/2003US6582899 Methods for identifying agents that cause a lethal phenotype, and agents thereof
06/24/2003US6582750 Mutant EGIII cellulase, DNA encoding such EGIII compositions and methods for obtaining same
06/24/2003US6582705 Acellular antibordetella vaccine
06/24/2003US6582696 Wound repair dressings and methods for their preservation
06/24/2003US6582391 Extracorporeal device comprising insoluble collagen fibrils; embedded within matrix are cultured vertebrate cells which secrete polypeptides; shunting patient's blood through apparatus and back into patient; polypeptide mixes with blood
06/24/2003CA2223694C Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
06/19/2003WO2003050287A2 Method for modifying plant morphology, biochemistry and physiology comprising expression of plant cytokinin oxidase
06/19/2003WO2003050283A2 A structure for presenting desired peptide sequences
06/19/2003WO2003050281A2 Fragments of the human zn-alpha2-glycolprotein and their use in methods of treatment of obesity
06/19/2003WO2003050275A2 Method of isolation and purification of trypsin from pronase and use thereof
06/19/2003WO2003050273A1 Human cell culture medium and culture method
06/19/2003WO2003050272A2 Bone development model
06/19/2003WO2003050271A2 In vitro production of dendritic cells from cd14+ monocytes
06/19/2003WO2003050270A1 Method for producing stem cells with increased developmental potential
06/19/2003WO2003050267A2 Method of isolating extract from the euphorbaciae obesa plant and methods for using the same
06/19/2003WO2003050266A2 Tissue engineered cellular sheets, methods of making and use thereof
06/19/2003WO2003050265A2 Compositions and methods for normalizing assays
06/19/2003WO2003050262A2 Method for the generation of antigen-specific lymphocytes
06/19/2003WO2003050255A2 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
06/19/2003WO2003050254A2 Novel chimeric tnf ligands
06/19/2003WO2003050251A2 Hematopoietic cells from human embryonic stem cells
06/19/2003WO2003050250A2 Chondrocyte precursors derived from human embryonic stem cells
06/19/2003WO2003050249A2 Islet cells from human embryonic stem cells
06/19/2003WO2003050247A2 Antisense modulation of mhc class ii transactivator expression
06/19/2003WO2003050238A2 Receptor-targeted adenoviral vectors
06/19/2003WO2003050236A2 Human genes and gene expression products isolated from human prostate
06/19/2003WO2003050235A2 Polynucleotide encoding a novel human potassium channel alpha-subunit, k+alpham2
06/19/2003WO2003050233A2 Gene promoters
06/19/2003WO2003050140A1 Tumor antigens
06/19/2003WO2003050128A1 Phosphonates useful as modulators of t $g(g)9$g(d)2 lymphocyte activity
06/19/2003WO2003049783A2 Device and methods for harvesting tissue samples of known geometry
06/19/2003WO2003049767A2 Method of large scale production of hepatitis a virus
06/19/2003WO2003049754A1 The use of osteogenic growth peptide in the enhancement of haemopoiesis
06/19/2003WO2003049703A2 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
06/19/2003WO2003049686A2 Stabilization of hypoxia inducible factor (hif) alpha
06/19/2003WO2003049626A1 Method and apparatus for production of a skin graft and the graft produced thereby
06/19/2003WO2003027252A3 Isolated dna molecules encoding humanized calcitonin gene-related peptide receptor, related non-human transgenic animals and assay methods
06/19/2003WO2003007790A3 Hybrid biologic/synthetic porous extracellular matrix scaffolds
06/19/2003WO2002077237A3 Transporters and ion channels
06/19/2003WO2002062847A3 Superficial zone protein and methods of making and using same
06/19/2003WO2002044342A9 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof
06/19/2003WO2002043660A3 Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment
06/19/2003WO2002042462A3 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
06/19/2003WO2002034899A3 Tec kinase assay
06/19/2003WO2002029058A3 Human proteins, polynucleotides encoding them and methods of using the same
06/19/2003WO2002004514A3 Compositions and methods for the therapy and diagnosis of lung cancer
06/19/2003WO2001015676A9 Compositions and methods for modulating hdl cholesterol and triglyceride levels
06/19/2003WO2001008635A3 Calcium channel transport polynucleotides, polypeptides, and antibodies
06/19/2003US20030115636 DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants
06/19/2003US20030115635 Controlling gene expression, apoptosis in plants
06/19/2003US20030115634 Dna sequence from Plasmodium; detection of herbicides, viricides, bactericides, fungicides
06/19/2003US20030115631 Transgenic plants; prevent diseases
06/19/2003US20030115627 Genetic engineering; isolated nucleic acid
06/19/2003US20030115622 Production of avian embryonic germ (eg) cell lines by prolonged culturing of pgc's, use thereof for cloning and chimerization
06/19/2003US20030115619 Animal with reduced sensitivity to disease
1 ... 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 ... 1827